Literature DB >> 27751377

Malignant Pleural Mesothelioma: The Need to Move from Research to Clinical Practice.

Caterina Ledda1, Venerando Rapisarda2.   

Abstract

Entities:  

Year:  2016        PMID： 27751377     DOI： 10.1016/j.arcmed.2016.08.009

Source DB:  PubMed          Journal:  Arch Med Res        ISSN： 0188-4409            Impact factor:   2.235


× No keyword cloud information.
  5 in total

1.  Dysregulation of microRNAs and tRNA-derived ncRNAs in mesothelial and mesothelioma cell lines after asbestiform fiber exposure.

Authors:  Alfredo Pulvirenti; Carla Loreto; Veronica Filetti; Alessandro La Ferlita; Antonio Di Maria; Venera Cardile; Adriana C E Graziano; Venerando Rapisarda; Caterina Ledda
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

2.  Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report.

Authors:  Giuseppe Angelico; Rosario Caltabiano; Carla Loreto; Antonio Ieni; Giovanni Tuccari; Caterina Ledda; Venerando Rapisarda
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

3.  Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.

Authors:  Caterina Ledda; Paola Senia; Venerando Rapisarda
Journal:  Cancers (Basel)       Date:  2018-06-15       Impact factor: 6.639

4.  Defense and protection mechanisms in lung exposed to asbestiform fiber: the role of macrophage migration inhibitory factor and heme oxygenase-1.

Authors:  Carla Loreto; Rosario Caltabiano; Adriana Carol Eleonora Graziano; Sergio Castorina; Claudia Lombardo; Vera Filetti; Ermanno Vitale; Giuseppe Rapisarda; Venera Cardile; Caterina Ledda; Venerando Rapisarda
Journal:  Eur J Histochem       Date:  2020-04-16       Impact factor: 3.188

5.  Epidemiological Research on Occupational and Environmental Carcinogens.

Authors:  Caterina Ledda
Journal:  Int J Environ Res Public Health       Date:  2021-02-24       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.